approved EB-1A
Postdoctoral Research Fellow
Translational Computational Oncology · Iran · 2025-05-13
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 7 peer-reviewed journal articles, including two as first author, in the field of oncology.
Judging (Met)
The petitioner completed 40 peer reviews, confirming her standing as a trusted expert for scientific journals.
Original Contributions (Met)
Her work in drug repurposing and vaccine design has been cited 377 times, placing her in the top 1% of her field.
Why This Petition Was Approved
The petition was approved based on 7 peer-reviewed journal articles and 377 citations from researchers in 56 countries. The applicant demonstrated her expert status through 40 completed peer reviews for scientific journals. Additionally, her ranking in the top 1% of highly cited researchers in vaccine therapy and international funding support from the Biotechnology Development Council of Iran satisfied the EB-1A criteria.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Evidence Submitted
- 7 peer-reviewed journal articles (2 as first author)
- 377 citations across 56 countries
- Ranked among the top 1% most highly cited researchers in vaccine therapy over the past decade
- 40 completed peer reviews for scientific journals
- International funding recognition
Similar Cases
Research Scientist
Biotechnology · China
WeGreened EB-1A approved
369 days 2025-01-15
The petition was approved based on the petitioner's 47 peer-reviewed publications in top-tier journals and a high citation count of 2,811. Additionally, her 48 journal reviews served as evidence of her judging the work of others. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging roles.
Research Assistant
Biotechnology · India
WeGreened EB-1A approved
Delaware 7 days 2022-03-24
The petition was approved based on 9 peer-reviewed articles published in international journals and a high citation count of 620. Her authority was further evidenced by 16 peer-review invitations and funding from the Coalition for Epidemic Preparedness Innovations. She was ranked in the top 1% of cited authors in her specific subfield over the last 3 years.
Postdoctoral Researcher
Biotechnology · India
WeGreened EB-1A approved
Pennsylvania 836 days 2026-01-21
The petition was approved based on a record of 17 peer-reviewed articles and 1,210 citations, demonstrating extensive independent reliance by the research community. The petitioner also provided evidence of 13 completed manuscript reviews for respected journals. Approval was further supported by original contributions in structure-guided HIV vaccine design and nucleic acid-based strategies for SARS-CoV-2.
Postdoctoral Researcher
Biotechnology
WeGreened EB-1A approved
New York 8 days 2025-05-08
The petition satisfied the EB-1A criteria through a high citation count of 4,265 and an h-index of 17, placing the applicant in the top 3% of researchers in medicine. Approval was further supported by a robust publication record in top-tier journals and extensive experience performing over 30 peer reviews for prestigious publications like Science Immunology.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-13.
Browse all casesAt a Glance
Outcome approved
Processing 15 days
Criteria Met 3 / 3
Evidence Types 5
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist